Weekly HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings

June 27, 2018 - By Rhonda Roth

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Corporate Logo

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings Coverage

A total of 2 analysts rate HTG Molecular Diagnostics (NASDAQ:HTGM) as follows: 2 “Buy”, 0 “Hold” and 0 “Sell”. Тherefore 100% are bullish. (NASDAQ:HTGM) has 11 ratings reports on Jun 27, 2018 according to StockzIntelligence. On Monday, January 8 the stock of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) has “Buy” rating given by Canaccord Genuity. On Friday, January 5 the firm has “Buy” rating by Canaccord Genuity given. On Tuesday, May 8 the rating was maintained by H.C. Wainwright with “Buy”. On Thursday, February 1 the firm has “Buy” rating given by H.C. Wainwright. On Friday, June 8 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) rating. H.C. Wainwright has “Buy” rating and $700 target. On Tuesday, May 22 the firm has “Buy” rating given by H.C. Wainwright. On Tuesday, April 17 the rating was maintained by H.C. Wainwright with “Buy”. In Friday, March 23 report Canaccord Genuity maintained the stock with “Buy” rating. On Wednesday, January 24 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. On Friday, March 23 the firm earned “Buy” rating by H.C. Wainwright. Listed here are HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) PTs and latest ratings.

08/06/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
22/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
08/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
17/04/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
23/03/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $5 New Target: $7 Maintain
23/03/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
01/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
24/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
08/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain
05/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain

HTGM is reaching $3.325 during the last trading session, after decreased 1.63%.Currently HTG Molecular Diagnostics, Inc. is uptrending after 3.13% change in last June 27, 2017. HTGM has also 149,326 shares volume. HTGM underperformed by 9.44% the S&P500.

HTG Molecular Diagnostics, Inc. develops and markets services and products based on proprietary technology that facilitates the routine use of targeted molecular profiling.The firm is valued at $94.33 million. The companyÂ’s products, HTG Edge and HTG EdgeSeq platforms include instrumentation , consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.Currently it has negative earnings. The Company’s platforms generate a molecular profiling library for detection using next-generation sequencing.

There’s a significant HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) news released by Seekingalpha.com. It’s a report titled: “HTG Molecular: Entering Stage Of Growth And Momentum” on June 11, 2018.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.